SynthesisScientific reports2025
Tranexamic acid in ear surgery: enhancing surgical field visibility and reducing bleeding-a systematic review and meta analysis.
Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Tranexamic acid can reduce blood loss and improve visibility in otological surgeries: a systematic review and meta-analysis of randomised controlled trials.The Journal of laryngology and otology · 2025Pooled it
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ear surgeries such as mastoidectomy require a clear surgical field with minimal bleeding for optimal visualization and outcomes. However, bleeding during these microscopic and endoscopic procedures can obscure the surgeon's view and potentially impact surgical precision and efficiency. The study aimed to identify the effect of intravenous tranexamic acid during ear surgery. PubMed/MEDLINE, Cochrane Library, and Embase were systematically searched from inception through August 31, 2024. Two authors also manually and independently searched all relevant studies. We included RCTs with (1) patients diagnosed with otitis media or middle ear infection; (2) interventions included intravenous tranexamic acid during ear surgery as mastoidectomy; (3) comparisons were specified as normal saline or no treatment; and (4) outcomes were subjective score (bleeding score and surgeon satisfaction), and objective markers (amount of bleeding, duration of surgery, and mean arterial pressure [MAP]). Data extraction was completed independently by 2 extractors and cross-checked for research integrity. The pairwise meta-analysis was performed to compare the treatment group with control used in ear surgery. Hedges' g standardized mean differences (SMDs) and mean difference (MD) were used for improvement in all outcomes. Efficacy outcomes included subjective scores as bleeding score and surgeon satisfaction, as well as objective markers measuring amount of bleeding, duration of surgery, and MAP. A comprehensive literature search was conducted which identified 4 RCTs with 248 patients. In subjective score, the pooled SMD 3.871 (95% CI 0.508, 7.234) for surgeon satisfaction between treatments for controls was significantly increased. In objective markers, the pooled MD for amount of bleeding and MAP were - 28.484 ml (95% CI - 35.785, - 21.182) and - 2.874 mmHg (95% CI - 4.732, - 1.015), indicating that the intravenous tranexamic acid during ear surgery significantly reduced amount of bleeding and MAP. The findings of this meta-analysis indicate that intravenous tranexamic acid can be an effective method for reducing bleeding during ear surgery. This is achieved by significantly improving the surgical field of view and lowering MAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.